UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pridopidine for the treatment of motor function in patients with Huntington's disease (MermaiHD): a phase 3, randomised, double-blind, placebo-controlled trial

Lancet neurology, 2011-12, Vol.10 (12), p.1049-1057

2011

Volltextzugriff (PDF)

A double-blind, randomized, cross-over, placebo-controlled, pilot trial with Sativex in Huntington’s disease

Journal of neurology, 2016-07, Vol.263 (7), p.1390-1400

2016

Volltextzugriff (PDF)

Profile of pridopidine and its potential in the treatment of Huntington disease: the evidence to date

Drug design, development and therapy, 2015-01, Vol.9, p.5827-5833

2015

Volltextzugriff (PDF)

Half a century of L-DOPA

Current topics in medicinal chemistry, 2009-07, Vol.9 (10), p.880

2009

Volltextzugriff (PDF)

Trehalose improves human fibroblast deficits in a new CHIP-mutation related ataxia

PloS one, 2014-09, Vol.9 (9), p.e106931-e106931

2014

Volltextzugriff (PDF)

Riluzole in Huntington's disease: a 3-year, randomized controlled study

Annals of neurology, 2007-09, Vol.62 (3), p.262-272

2007

Volltextzugriff (PDF)

Natural cannabinoids improve dopamine neurotransmission and tau and amyloid pathology in a mouse model of tauopathy

Journal of Alzheimer's disease, 2013-01, Vol.35 (3), p.525-539

2013

Volltextzugriff (PDF)

Trehalose reverses cell malfunction in fibroblasts from normal and Huntington's disease patients caused by proteosome inhibition

PloS one, 2014-02, Vol.9 (2), p.e90202

2014

Volltextzugriff (PDF)

Trehalose ameliorates dopaminergic and tau pathology in parkin deleted/tau overexpressing mice through autophagy activation

Neurobiology of disease, 2010-09, Vol.39 (3), p.423-438

2010

Volltextzugriff (PDF)

The effects of parkin suppression on the behaviour, amyloid processing, and cell survival in APP mutant transgenic mice

Experimental neurology, 2010, Vol.221 (1), p.54-67

2010

Volltextzugriff (PDF)

One-year safety and tolerability profile of pridopidine in patients with Huntington disease

Neurology, 2013-03, Vol.80 (12), p.1086-1094

2013

Volltextzugriff (PDF)

Anesthesia with isoflurane increases amyloid pathology in mice models of Alzheimer's disease

Journal of Alzheimer's disease, 2010-01, Vol.19 (4), p.1245-1257

2010

Volltextzugriff (PDF)

Drug-Induced Parkinsonism in the Elderly: Incidence, Management and Prevention

Drugs & aging, 2012-02, Vol.29 (2), p.105-118

2012

Volltextzugriff (PDF)

Glial Dysfunction in Parkin Null Mice: Effects of Aging

The Journal of neuroscience, 2008-01, Vol.28 (3), p.598-611

2008

Volltextzugriff (PDF)

Trehalose Protects from Aggravation of Amyloid Pathology Induced by Isoflurane Anesthesia in APPswe Mutant Mice

Current Alzheimer research, 2012-03, Vol.9 (3), p.334-343

2012

Volltextzugriff (PDF)

New World, old views

The Lancet (British edition), 2018-12, Vol.392 (10164), p.2551-2552

2018

Volltextzugriff (PDF)

Vitamin B6 Deficiency in Patients With Parkinson Disease Treated With Levodopa/Carbidopa

Clinical neuropharmacology, 2020-09, Vol.43 (5), p.151-157

2020

Volltextzugriff (PDF)

Mortality, oxidative stress and tau accumulation during ageing in parkin null mice

Journal of neurochemistry, 2007-10, Vol.103 (1), p.98-114

2007

Volltextzugriff (PDF)

Revisiting genotype-phenotype overlap in neurogenetics: Triplet-repeat expansions mimicking spastic paraplegias

Human mutation, 2012-09, Vol.33 (9), p.1315-1323

2012

Volltextzugriff (PDF)

Levodopa toxicity in foetal rat midbrain neurones in culture: modulation by ascorbic acid

Neuroreport, 1993-04, Vol.4 (4), p.438-440

1993

Volltextzugriff (PDF)

Placebo effect characteristics observed in a single, international, longitudinal study in Huntington's disease

Movement disorders, 2012-03, Vol.27 (3), p.439-442

2012

Volltextzugriff (PDF)

Parkinsonism and other movement disorders in 23 cases of neurocysticercosis

Parkinsonism & related disorders, 2017-09, Vol.42, p.47-53

2017

Volltextzugriff (PDF)

Parkin deficiency increases the resistance of midbrain neurons and glia to mild proteasome inhibition: the role of autophagy and glutathione homeostasis

Journal of neurochemistry, 2009-09, Vol.110 (5), p.1523-1537

2009

Volltextzugriff (PDF)

Glial Cells as Players in Parkinsonism: The “Good,” the “Bad,” and the “Mysterious” Glia

The Neuroscientist (Baltimore, Md.), 2008-12, Vol.14 (6), p.544-560

2008

Volltextzugriff (PDF)

Trehalose rescues glial cell dysfunction in striatal cultures from HD R6/1 mice at early postnatal development

Molecular and cellular neuroscience, 2016-07, Vol.74, p.128-145

2016

Volltextzugriff (PDF)

1 – 25 von 116

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(109)
Mit Volltextzugriff
(91)

Publikationsform

Artikel
(114)
Berichte
(2)

Sprache

Englisch
(110)
Japanisch
(15)
Spanisch
(6)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pridopidine for the treatment of motor function in patients with Huntington's disease (MermaiHD): a phase 3, randomised, double-blind, placebo-controlled trial

A double-blind, randomized, cross-over, placebo-controlled, pilot trial with Sativex in Huntington’s disease

Profile of pridopidine and its potential in the treatment of Huntington disease: the evidence to date

Half a century of L-DOPA

Trehalose improves human fibroblast deficits in a new CHIP-mutation related ataxia

Riluzole in Huntington's disease: a 3-year, randomized controlled study

Natural cannabinoids improve dopamine neurotransmission and tau and amyloid pathology in a mouse model of tauopathy

Trehalose reverses cell malfunction in fibroblasts from normal and Huntington's disease patients caused by proteosome inhibition

Trehalose ameliorates dopaminergic and tau pathology in parkin deleted/tau overexpressing mice through autophagy activation

The effects of parkin suppression on the behaviour, amyloid processing, and cell survival in APP mutant transgenic mice

One-year safety and tolerability profile of pridopidine in patients with Huntington disease

Anesthesia with isoflurane increases amyloid pathology in mice models of Alzheimer's disease

Drug-Induced Parkinsonism in the Elderly: Incidence, Management and Prevention

Glial Dysfunction in Parkin Null Mice: Effects of Aging

Trehalose Protects from Aggravation of Amyloid Pathology Induced by Isoflurane Anesthesia in APPswe Mutant Mice

New World, old views

Vitamin B6 Deficiency in Patients With Parkinson Disease Treated With Levodopa/Carbidopa

Mortality, oxidative stress and tau accumulation during ageing in parkin null mice

Revisiting genotype-phenotype overlap in neurogenetics: Triplet-repeat expansions mimicking spastic paraplegias

Levodopa toxicity in foetal rat midbrain neurones in culture: modulation by ascorbic acid

Placebo effect characteristics observed in a single, international, longitudinal study in Huntington's disease

Parkinsonism and other movement disorders in 23 cases of neurocysticercosis

Parkin deficiency increases the resistance of midbrain neurons and glia to mild proteasome inhibition: the role of autophagy and glutathione homeostasis

Glial Cells as Players in Parkinsonism: The “Good,” the “Bad,” and the “Mysterious” Glia

Trehalose rescues glial cell dysfunction in striatal cultures from HD R6/1 mice at early postnatal development

Suchergebnisse filtern